Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC. Lee EJ, Oh SY, Lee YW, Kim JY, et al. Clin Cancer Res 2024;30:1582-1594.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lee EJ, Oh SY, Lee YW, Kim JY, et al. Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC. Clin Cancer Res 2024;30:1582-1594.
PMID: 38330145